98%
921
2 minutes
20
Six new Ir(III) complexes containing the 3'-phosphino-2,2':5',2''-terthiophene (PT3) ligand in three different coordination modes are reported. The electronic properties of the complexes are characterized by cyclic voltammetry, absorption, emission and time-resolved transient absorption spectroscopies and DFT/TDDFT calculations. The electrochemical and photophysical behaviour of the complexes was found to be dominated by the PT3 ligand. For the complexes in which the PT3 ligand is coordinated in a bidentate P,S or P,C mode, the lowest energy absorption band is attributed to π-π* PT3 localized transitions consistent with observations from DFT calculations. Emission quantum yields are low in all cases (<0.07) and emission lifetimes are short (<50 ns). Intersystem crossing leads to a long-lived triplet state ((3)L) also localized on the PT3 group. In the complex where the PT3 ligand is coordinated only via the phosphine, TDDFT calculations suggest that there is some MLCT (and Cl-PT3 CT) character in the lowest energy transition.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c3dt51320c | DOI Listing |
Molecules
June 2025
Institute of Chemistry, St. Petersburg University, Universitetskii pr. 26, 198504 St. Petersburg, Russia.
In this work, two series of Au(III) and Pt(II) alkynylphosphonium complexes of composition [M(CNC)(C-L-P(CH)Ph)]- (n = 0) and - (n = 1), (CNC = 2,6-diphenylpyridine; L = phenyl, biphenyl, naphthyl) were synthesized and characterized to discover the similarities and differences in photophysical properties between isoelectronic metallocentres. It is shown that Au(III) and Pt(II) complexes obtained demonstrate different photophysical properties despite isoelectronic metal centres, and some reasons for that are discussed based on experimental data and quantum-chemical calculation results. Complex also demonstrated the first example of room-temperature solution phosphorescence in the family of [Pt(CNC)(alkynyl)] complexes.
View Article and Find Full Text PDFInorg Chem
May 2025
Institute of Chemistry, St Petersburg University, Universitetskii pr. 26, St. Petersburg 198504, Russia.
Four bis-alkynyl Pt(II) complexes [Pt(dtbpy)(C-L-P(O)Ph)] with = 4,4'-ditertbutyl-2,2'-bipyridine and alkynylphosphine oxide ligands (L = no linker, ; phenyl, ; biphenyl, ; naphthyl, ) have been synthesized and fully characterized by spectroscopic methods and single crystal XRD analysis. It has been found that the nature of the π-conjugated linker is a key factor in fine-tuning the emission energy of the complexes in solution and in achieving the aggregation-induced phosphorescence enhancement (AIPE) effect for complex with the most compact linker. Phosphine oxide fragment, which can be involved in weak intermolecular interactions, promotes the existence of two solid forms with different luminescence properties.
View Article and Find Full Text PDFDalton Trans
May 2025
Université de Strasbourg, CNRS, UMR 7140, F-67000 Strasbourg, France.
To mimic the structural aspects of staurosporine, a potent but unspecific kinase inhibitor, several coordination compounds based on two readily available diimine ligands containing hydrogen bonding donor/acceptor sites (NH-CO fragment) have been designed and synthesized. These complexes are constructed around Ru(II) and Pt(II) metal centers. A total of 9 compounds, named Ru(1)-(5) and Pt(1)-(4), were obtained through straightforward synthetic approaches.
View Article and Find Full Text PDFAnn Surg Oncol
March 2025
Department of Pathology, Saitama Cancer Center, Saitama, Japan.
Background: Little is known about the survival impacts of mitochondrial status in esophageal squamous cell carcinoma (ESCC) patients who undergo neoadjuvant chemotherapy (NAC) followed by surgery.
Methods: In total, 260 pre-NAC samples from ESCC patients were analyzed. Mitochondrial status was estimated employing an objective, immunohistochemistry-based system (Mito-score).
Urologie
October 2024
Urologische Klinik und Poliklinik, des Universitätsklinikum rechts der Isar der Technischen Universität München, München, Deutschland.
The risk of recurrence in patients with muscle invasive bladder cancer (MIBC) after radical cystectomy depends on the pathological tumor stage. In particular, patients with lymph node metastasis (pN+), locally advanced (≥pT3), or residual muscle invasive tumor despite neoadjuvant chemotherapy are at high risk. Currently, the importance of adjuvant therapy with immune checkpoint inhibitors is increasing in the context of perioperative systemic therapeutic concepts.
View Article and Find Full Text PDF